- Tytuł:
- ELRANATAMAB, A B-CELL MATURATION ANTIGEN-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM THE MAGNETISMM-3 STUDY
- Autorzy:
- Źródło:
- In Hematology, Transfusion and Cell Therapy October 2023 45 Supplement 4:S404-S405
Czasopismo naukowe